SUMMARY1. The whole-cell patch clamp and intracellular perfusion techniques were used for studying the effects of atropine and other muscarinic acetylcholine receptor (mAChR) antagonists on the L-type calcium currents ('Ca) in frog and rat ventricular myocytes, and on the mAChR-activated K+ current ('K(ACh)) in frog atrial myocytes.2. In frog ventricular myocytes, atropine (01 nm to I /,tM) reversed the inhibitory effect of acetylcholine (ACh, 1 nM) on 'Ca previously stimulated by isoprenaline (Iso, 2 JM), a /l-adrenergic agonist. However, in the concomitant presence of Iso, ACh and atropine, 'Ca was > 50 % larger than in Iso alone.3. The effects of atropine were then examined in the absence of mAChR agonists. 4. Atropine (1 M) had no effect on frog ICa (i) under basal conditions, (ii) upon stimulation of ICa by the dihydropyridine agonist (-)-Bay K 8644 (1 aM), or (iii) when ICa had been previously stimulated by intracellular perfusion with cyclic AMP (3 AM). However, atropine increased Jca after a stimulation by forskolin (0 3 1M).Therefore, an increased adenylyl cyclase activity was required for atropine to produce its stimulatory effect on Jca 5. The order of potency of mAChR antagonists to reverse the inhibitory effect of ACh on Iso elevated ICa in frog ventricle was atropine > AF-DX 116 > pirenzepine.In the absence of ACh, mAChR antagonists produced their stimulatory effect on Iso elevated ICa with the same order of potency.6. Intracellular substitution of Gpp(NH)p (5'-guanylylimidiphosphate) for GTP (420 AtM) induced a strong inhibition of frog Ica in the presence of Iso (2 aM).